Delivery Order SPE2DE24DA017-SPE2D625F7826

Award Date 10/18/24
Potential Completion Date 10/23/24
Potential Value $5.3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $3,939.62 fixed-price delivery order is for the Arthrex ACP Double Syringe System, which will be delivered by November 22, 2024. Arthrex, a for-profit Subchapter S Corporation, has a significant single-award Indefinite Delivery Contract (IDC) valued at $471,048,172.66 with the DLA that allows...
This federal contract award, valued at $2,475.00, was issued by the Medical Supply Chain of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the provision of Arthrex's ACP Double Syringe System, a specialized medical device used in orthopedic procedures. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type and has an ultimate completion date of October 21,...
The federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, is for the delivery of the ARTHREX ACP DOUBLE SYRINGE SYSTEM. The $5,775.00 fixed-price with economic price adjustment contract was awarded by the Medical Supply Chain of the Defense Logistics Agency, a defense agency. The contract has an ultimate completion date of October 22, 2024 and does not have a set-aside designation, indicating Arthrex's strong competitive position....
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, is for the provision of the ARTHREX ACP DOUBLE SYRINGE SYSTEM. The $1,650 fixed-price with economic price adjustment contract is a delivery order awarded by the Defense Logistics Agency's Medical Supply Chain and has a completion date of June 18, 2025. The contract is not set aside for a specific business type. Arthrex holds a significant single-award Indefinite Delivery Contract...
This contract award from the Defense Logistics Agency (DLA) is for the Arthrex ACP Double Syringe System, a medical product provided by Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The fixed-price contract with economic price adjustment, valued at $4,125.00, has a completion date of January 10, 2025. Arthrex, a for-profit Subchapter S Corporation, has a robust portfolio of orthopedic medical products used by government healthcare systems, particularly...
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, is for the delivery of the ARTHREX ACP DOUBLE SYRINGE SYSTEM. The $2,475.00 fixed-price with economic price adjustment contract has an ultimate completion date of July 8, 2025 and was awarded on July 2, 2025 by the Defense Logistics Agency's Medical Supply Chain. The contract is not set aside for a specific business type. Arthrex, a for-profit Subchapter S Corporation, has...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The $2,475.00 fixed-price with economic price adjustment delivery order contract is for the Arthrex ACP Double Syringe System, with a completion date of June 12, 2025. Arthrex, a for-profit Subchapter S Corporation, is the prime contractor and has not identified any subcontractors. This contract is not set aside...
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, is for the delivery of the ARTHREX ACP DOUBLE SYRINGE SYSTEM. The $2,475.00 fixed-price with economic price adjustment contract was awarded on June 25, 2025, with a completion date of June 30, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain and is not set aside for any specific business type. Arthrex holds a significant single-award Indefinite...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $1,650.00 fixed-price with economic price adjustment delivery order is for the Arthrex ACP Double Syringe System, a specialized medical device used for orthopedic procedures. The contract has an ultimate completion date of December 27, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in...
This federal contract award is for the Arthrex ACP Double Syringe System, a medical device supplied by Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The $1,650.00 fixed-price delivery order contract with economic price adjustment was awarded on June 6, 2025, with a completion date of June 11, 2025. The contracting agency is the Defense Logistics Agency's Medical Supply Chain, a civilian agency supporting the Department of Defense. The contract is not set...
  • SPE2DE24DA017
    Indefinite Delivery Contract
  • SPE2DE24DA017-SPE2D625F7826
    Delivery Order

The federal contract award is for the Arthrex ACP Double Syringe System, awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The fixed-price contract with economic price adjustment has a ceiling value of $5,254.92 and an ultimate completion date of October 23, 2024. Arthrex, a for-profit Subchapter S Corporation, has a significant single-award Indefinite Delivery Contract (IDC) with the DLA valued at $471,048,172.66, which allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders. This contract is not designated as a set-aside contract.

Generated 1/17/25, 9:26 AM